Individuals who are double-vaccinated or recovered from COVID-19 have “virtually no protection” against the Omicron variant, according to a peer-reviewed study.
The research, led by Rudolf Valenta of the Medical University of Vienna, found that only people who had received the third dose of a COVID-19 vaccine can form antibodies that could partially block Omicron, although noting that the protection is far from optimal.
“The third vaccination developed protective antibodies in many individuals,” Valenta said, adding that “there is also a significant proportion (20 percent) in whom no protection was established.”
According to results of the study recently published in the journal Allergy, researchers with the Medical University of Vienna examined an Austrian subpopulation of people who had been vaccinated or recovered from the CCP (Chinese Communist Party) virus. Scientists examined individuals’ antibody status and protection against the Wuhan, Delta, and Omicron variants, strains that are currently prevalent in the European country.
The study involved people who received all types of COVID-19 vaccines and vaccine combinations currently licensed in Austria.
Regarding the Omicron variant, researchers developed a test for the previous variants that investigates whether the COVID-19 strain can bind to the receptor on human cells via its receptor-binding domain (RBD).
“The results showed that both COVID-19 convalescent individuals and individuals who had been vaccinated twice had developed antibody protection against Delta. However, the antibodies were not able to block receptor binding against Omicron,” the researchers found.
An RBD is a key part used by a virus, including the CCP virus, to enter the “spike protein” domain that allows viruses to dock to the human body, gain entry into cells, and lead to infection.
The RBD differed only slightly in all CCP virus variants previously known, researchers said, adding that the COVID-19 vaccines that are currently available could provide protection against infections caused by these previous strains.
“Omicron is the first variant that differs greatly from the previous variants in RBD, consequently, infections with the previous variants and currently available vaccines provide little or no protection against Omicron,” the study found.
The researchers noted that the best protection would be to develop a broadly effective combination vaccine that could protect against both the previous CCP virus variants and Omicron.
“Until we have such a vaccine, only repeated vaccinations with the existing vaccines will provide some protection,” Valenta said. “The protective effect achieved by vaccination can be evaluated with special tests that can be rapidly adapted to new virus variants.”
Omicron became dominant in the United States in December 2021 and other studies have already suggested it can evade protection from COVID-19 vaccines and prior infection better than Delta. Most previous studies have also found that natural immunity remains superior to vaccination, including while Delta was dominant.
In a recent study, antibody protection against the CCP virus among recovered individuals was detected at 20 months post-infection, adding to the body of evidence that such protection, known as natural immunity, is long-lasting.
From NTD News via our premium news partners at The Epoch Times.
They’re Trying to Shut Us Down
Over the last several months, I’ve lost count of how many times the powers-that-be have tried to shut us down. They’ve sent hackers at us, forcing us to take extreme measures on web security. They sent attorneys after us, but thankfully we’re not easily intimidated by baseless accusations or threats. They’ve even gone so far as to make physical threats. Those can actually be a bit worrisome but Remington has me covered.
For us to continue to deliver the truth that Americans need to read and hear, we ask you, our amazing audience, for financial assistance. We just launched a GiveSendGo page to help us pay the bills. It’s brand new so don’t be discouraged by the lack of donations there. It’s a funny reality that the fewer the donations that have been made, the less likely people are willing to donate to it. One would think this is counterintuitive, but sometimes people are skeptical because they think that perhaps there’s a reason others haven’t been donating. In our situation, we’re just getting started so please don’t be shy if you have the means to help.
Thank you and God bless!
JD Rucker
New studies of effectiveness of Ivermectin emerging every day. Peer-reviewed, large PSM study from Brazil finds, regular use of ivermectin as a prophylactic agent was associated with significantly reduced COVID-19 infection, hospitalization, and mortality rates. The study was published in the Cureus Journal of Medical Science. This medicine is proven over and over again to be effective for covid and flu like symptoms. You can get your ivermectin by visiting https://ivmcures.com
I quit working at shoprite to work online and with a little effort I easily bring in around $45 to 85 per/h. Without Ret a my doubt, this is the pay easiest and most financially HVU rewarding job I’ve ever had. I actually started 6 months ago and this has totally
changed my life………… http://upwork24.tk/